Safety profile of guselkumab in treatment of patients with psoriasis and coexisting hepatitis B or C: A multicenter prospective cohort study

被引：3
作者：
Huang, Yu-Huei [1 ,2 ]
Yen, Ju-Shao [1 ]
Li, Shu-Hao [1 ]
Chiu, Hsien-Yi [3 ,4 ,5 ,6 ]
机构：
[1] Chang Gung Mem Hosp, Dept Dermatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Med Res, Hsin Chu Branch, Hsinchu, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan
[6] Natl Taiwan Univ, Coll Med, Dept Dermatol, Taipei, Taiwan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 90卷 / 05期
关键词：
guselkumab; hepatitis B; hepatitis C; psoriasis; reactivation;
D O I：
10.1016/j.jaad.2024.01.039
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1083 / 1086
页数：4
相关论文
共 5 条
[1]   The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C [J].
Chiu, H. -Y. ;
Chen, C. -H. ;
Wu, M. -S. ;
Cheng, Y. -P. ;
Tsai, T. -F. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) :1295-1303
[2]   Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study [J].
Chiu, Hsien-Yi ;
Chiu, Ying-Ming ;
Liao, Nien-Feng Chang ;
Chi, Ching-Chi ;
Tsai, Tsen-Fang ;
Hsieh, Chang-Yu ;
Hsieh, Tsu-Yi ;
Lai, Kuo-Lung ;
Chiu, Tsu-Man ;
Wu, Nan-Lin ;
Hui, Rosaline Chung-yee ;
Lee, Chaw-Ning ;
Wang, Ting-Shun ;
Chen, Po-Hua ;
Yang, Chao-Chun ;
Huang, Yu-Huei .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) :337-344
[3]   Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study [J].
Chiu, Hsien-Yi ;
Hui, Rosaline Chung-yee ;
Huang, Yu-Huei ;
Huang, Ruey-Yun ;
Chen, Kai-Lung ;
Tsai, Ya-Chu ;
Lai, Po-Ju ;
Wang, Ting-Shun ;
Tsai, Tsen-Fang .
ACTA DERMATO-VENEREOLOGICA, 2018, 98 (09) :829-834
[4]   Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions [J].
Loomba, Rohit ;
Liang, T. Jake .
GASTROENTEROLOGY, 2017, 152 (06) :1297-1309
[5]   Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab [J].
Ting, Sze-Wen ;
Chen, Yi-Cheng ;
Huang, Yu-Huei .
CLINICAL DRUG INVESTIGATION, 2018, 38 (09) :873-880
1